[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)

Filing Impact

(Low)

Filing Sentiment

(Neutral)

Form Type

6-K

Rhea-AI Filing Summary

Analyzing...

07/17/2025 - 06:10 AM

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Ascentage Pharma Group International

NASDAQ:AAPG

AAPG Rankings

#2941 Ranked by Market Cap

N/A Ranked by Dividends

AAPG Latest News

Jul 17, 2025

Ascentage Pharma Announces Closing of Placement Shares in Top-Up Placement

Jul 14, 2025

Ascentage Pharma Announces Pricing of Top-Up Placement

Jul 14, 2025

Ascentage Pharma Announces Proposed Top-Up Placement

Jul 10, 2025

Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL

Jul 7, 2025

Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance

AAPG Latest SEC Filings

Jul 14, 2025

[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)

Jul 10, 2025

[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)

Jul 8, 2025

[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)

Jun 27, 2025

[6-K] Ascentage Pharma Group International Current Report (Foreign Issuer)

AAPG Stock Data

Market Cap 3.65B

Float 7.33M

Short Percent 0.16%

Industry Biotechnology

Sector Healthcare

Website Link

Country China

City Suzhou